Literature DB >> 22040100

Potent taccalonolides, AF and AJ, inform significant structure-activity relationships and tubulin as the binding site of these microtubule stabilizers.

Jing Li1, April L Risinger, Jiangnan Peng, Zhongliang Chen, Lihong Hu, Susan L Mooberry.   

Abstract

The taccalonolides are a class of microtubule stabilizing agents isolated from plants of the genus Tacca. In efforts to define their structure-activity relationships, we isolated five new taccalonolides, AC-AF and H2, from one fraction of an ethanol extract of Tacca plantaginea. The structures were elucidated using a combination of spectroscopic methods, including 1D and 2D NMR and HR-ESI-MS. Taccalonolide AJ, an epoxidation product of taccalonolide B, was generated by semisynthesis. Five of these taccalonolides demonstrated cellular microtubule-stabilizing activities and antiproliferative actions against cancer cells, with taccalonolide AJ exhibiting the highest potency with an IC(50) value of 4.2 nM. The range of potencies of these compounds, from 4.2 nM to >50 μM, for the first time provides the opportunity to identify specific structural moieties crucial for potent biological activities as well as those that impede optimal cellular effects. In mechanistic assays, taccalonolides AF and AJ stimulated the polymerization of purified tubulin, an activity that had not previously been observed for taccalonolides A and B, providing the first evidence that this class of microtubule stabilizers can interact directly with tubulin/microtubules. Taccalonolides AF and AJ were able to enhance tubulin polymerization to the same extent as paclitaxel but exhibited a distinct kinetic profile, suggesting a distinct binding mode or the possibility of a new binding site. The potencies of taccalonolides AF and AJ and their direct interaction with tubulin, together with the previous excellent in vivo antitumor activity of this class, reveal the potential of the taccalonolides as new anticancer agents.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22040100      PMCID: PMC3234588          DOI: 10.1021/ja209045k

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  12 in total

1.  Cabazitaxel.

Authors:  Matthew D Galsky; Argyris Dritselis; Peter Kirkpatrick; William K Oh
Journal:  Nat Rev Drug Discov       Date:  2010-09       Impact factor: 84.694

2.  Five taccalonolides from Tacca plantaginea.

Authors:  Z L Chen; J H Shen; Y S Gao; M Wichtl
Journal:  Planta Med       Date:  1997-02       Impact factor: 3.352

Review 3.  Microtubules and resistance to tubulin-binding agents.

Authors:  Maria Kavallaris
Journal:  Nat Rev Cancer       Date:  2010-02-11       Impact factor: 60.716

4.  Identification and biological activities of new taccalonolide microtubule stabilizers.

Authors:  Jiangnan Peng; April L Risinger; Gary A Fest; Evelyn M Jackson; Gregory Helms; Lisa A Polin; Susan L Mooberry
Journal:  J Med Chem       Date:  2011-08-11       Impact factor: 7.446

Review 5.  Microtubule-binding agents: a dynamic field of cancer therapeutics.

Authors:  Charles Dumontet; Mary Ann Jordan
Journal:  Nat Rev Drug Discov       Date:  2010-10       Impact factor: 84.694

6.  Microtubule interactions with chemically diverse stabilizing agents: thermodynamics of binding to the paclitaxel site predicts cytotoxicity.

Authors:  Rubén M Buey; Isabel Barasoain; Evelyn Jackson; Arndt Meyer; Paraskevi Giannakakou; Ian Paterson; Susan Mooberry; José M Andreu; J Fernando Díaz
Journal:  Chem Biol       Date:  2005-12

7.  Cellular studies reveal mechanistic differences between taccalonolide A and paclitaxel.

Authors:  April L Risinger; Susan L Mooberry
Journal:  Cell Cycle       Date:  2011-07-01       Impact factor: 4.534

8.  Taccalonolides E and A: Plant-derived steroids with microtubule-stabilizing activity.

Authors:  Tina L Tinley; Deborah A Randall-Hlubek; Rachel M Leal; Evelyn M Jackson; James W Cessac; James C Quada; Thomas K Hemscheidt; Susan L Mooberry
Journal:  Cancer Res       Date:  2003-06-15       Impact factor: 12.701

Review 9.  Microtubule active agents: beyond the taxane frontier.

Authors:  Patrick G Morris; Monica N Fornier
Journal:  Clin Cancer Res       Date:  2008-11-15       Impact factor: 12.531

10.  The taccalonolides: microtubule stabilizers that circumvent clinically relevant taxane resistance mechanisms.

Authors:  April L Risinger; Evelyn M Jackson; Lisa A Polin; Gregory L Helms; Desiree A LeBoeuf; Patrick A Joe; Elizabeth Hopper-Borge; Richard F Ludueña; Gary D Kruh; Susan L Mooberry
Journal:  Cancer Res       Date:  2008-11-01       Impact factor: 12.701

View more
  28 in total

Review 1.  Current advances of tubulin inhibitors as dual acting small molecules for cancer therapy.

Authors:  Kinsie E Arnst; Souvik Banerjee; Hao Chen; Shanshan Deng; Dong-Jin Hwang; Wei Li; Duane D Miller
Journal:  Med Res Rev       Date:  2019-02-11       Impact factor: 12.944

2.  Unravelling the covalent binding of zampanolide and taccalonolide AJ to a minimalist representation of a human microtubule.

Authors:  Pedro A Sánchez-Murcia; Alberto Mills; Álvaro Cortés-Cabrera; Federico Gago
Journal:  J Comput Aided Mol Des       Date:  2019-05-31       Impact factor: 3.686

3.  Taccalonolide Microtubule Stabilizers Generated Using Semisynthesis Define the Effects of Mono Acyloxy Moieties at C-7 or C-15 and Disubstitutions at C-7 and C-25.

Authors:  Antonius R B Ola; April L Risinger; Lin Du; Cynthia L Zammiello; Jiangnan Peng; Robert H Cichewicz; Susan L Mooberry
Journal:  J Nat Prod       Date:  2018-01-23       Impact factor: 4.050

4.  Melampodium leucanthum, a source of cytotoxic sesquiterpenes with antimitotic activities.

Authors:  Andrew J Robles; Jiangnan Peng; Rachel M Hartley; Brigette Lee; Susan L Mooberry
Journal:  J Nat Prod       Date:  2015-02-16       Impact factor: 4.050

Review 5.  Microtubule stabilizing agents as potential treatment for Alzheimer's disease and related neurodegenerative tauopathies.

Authors:  Carlo Ballatore; Kurt R Brunden; Donna M Huryn; John Q Trojanowski; Virginia M-Y Lee; Amos B Smith
Journal:  J Med Chem       Date:  2012-09-28       Impact factor: 7.446

Review 6.  Recent progress with microtubule stabilizers: new compounds, binding modes and cellular activities.

Authors:  Cristina C Rohena; Susan L Mooberry
Journal:  Nat Prod Rep       Date:  2014-03       Impact factor: 13.423

7.  Hydrolysis reactions of the taccalonolides reveal structure-activity relationships.

Authors:  Jing Li; Jiangnan Peng; April L Risinger; Susan L Mooberry
Journal:  J Nat Prod       Date:  2013-07-15       Impact factor: 4.050

Review 8.  Microtubule-stabilizing agents as potential therapeutics for neurodegenerative disease.

Authors:  Kurt R Brunden; John Q Trojanowski; Amos B Smith; Virginia M-Y Lee; Carlo Ballatore
Journal:  Bioorg Med Chem       Date:  2013-12-30       Impact factor: 3.641

9.  Taccalonolide binding to tubulin imparts microtubule stability and potent in vivo activity.

Authors:  A L Risinger; J Li; M J Bennett; C C Rohena; J Peng; D C Schriemer; S L Mooberry
Journal:  Cancer Res       Date:  2013-09-18       Impact factor: 12.701

Review 10.  Taccalonolide microtubule stabilizers.

Authors:  Jing Li; April L Risinger; Susan L Mooberry
Journal:  Bioorg Med Chem       Date:  2014-01-15       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.